GEODE CAPITAL MANAGEMENT, LLC - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 35 filers reported holding SURFACE ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$580,386
+110.6%
667,418
+69.3%
0.00%
Q1 2023$275,545
+87097.8%
394,312
+2.1%
0.00%
Q4 2022$316
-99.9%
386,312
+3.7%
0.00%
Q3 2022$387,000
-32.6%
372,614
+6.3%
0.00%
Q2 2022$574,000
-67.6%
350,411
-41.8%
0.00%
Q1 2022$1,769,000
-45.8%
601,779
-11.9%
0.00%
Q4 2021$3,264,000
-29.2%
682,853
+12.1%
0.00%
-100.0%
Q3 2021$4,612,000
+25.4%
609,257
+23.6%
0.00%0.0%
Q2 2021$3,677,000
+169.6%
493,021
+181.8%
0.00%
Q1 2021$1,364,000
-5.2%
174,937
+12.2%
0.00%
Q4 2020$1,439,000
+59.9%
155,859
+19.5%
0.00%
Q3 2020$900,000
+66.4%
130,443
+57.9%
0.00%
Q2 2020$541,000
+273.1%
82,616
+5.8%
0.00%
Q1 2020$145,000
-50.3%
78,051
-50.0%
0.00%
Q4 2019$292,000
+165.5%
156,102
+100.0%
0.00%
Q3 2019$110,000
-50.2%
78,051
-0.8%
0.00%
Q2 2019$221,000
-62.4%
78,699
-36.2%
0.00%
Q1 2019$588,000
-40.5%
123,295
-47.2%
0.00%
Q4 2018$988,000
+16.5%
233,490
+201.0%
0.00%
Q3 2018$848,000
-30.7%
77,571
+3.4%
0.00%
Q2 2018$1,223,00075,0160.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$21,972,0003.87%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,272,0000.65%
Parkman Healthcare Partners LLC 228,267$1,703,0000.37%
SILVERARC CAPITAL MANAGEMENT, LLC 94,539$705,0000.31%
C M BIDWELL & ASSOCIATES LTD 33,030$246,0000.16%
GSA CAPITAL PARTNERS LLP 115,147$859,0000.10%
Knights of Columbus Asset Advisors LLC 113,594$847,0000.08%
ARK Investment Management 4,478,546$33,410,0000.06%
Ipswich Investment Management Co., Inc. 32,000$239,0000.06%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 27,400$204,0000.04%
View complete list of SURFACE ONCOLOGY INC shareholders